Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -31.47%-1.46M | 61.10%-648K | -94.81%-263K | -156.57%-4.16M | -99.20%-1.25M | -7.36%-1.11M | -4,371.79%-1.67M | -135K | -75.81%-1.62M | -1,206.25%-627K |
| Net income from continuing operations | 191.59%12.1M | -256.67%-34.9M | -102.14%-20.6M | -59.71%-40.71M | -25.22%-7.52M | -185.21%-13.21M | -86.38%-9.79M | -6.17%-10.19M | -36.41%-25.49M | 36.01%-6.01M |
| Operating gains losses | ---- | ---- | 62.62%7.51M | 473.99%8.65M | -485.66%-4.33M | 445.43%6.42M | 299.28%1.95M | 43.51%4.62M | 2,222.54%1.51M | -66.30%1.12M |
| Remuneration paid in stock | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 304.93%1.15M | --0 |
| Other non cashItems | -224.54%-13.95M | 88.11%23.27M | 147.42%12.07M | 32.23%24.67M | -213.66%-3.77M | 139.05%11.2M | 136.80%12.37M | -10.25%4.88M | 6.60%18.66M | -44.03%3.32M |
| Change In working capital | -57.24%387K | 534.15%2.34M | 35.59%762K | 26.48%3.23M | 48.19%1.39M | 340.05%905K | -64.59%369K | -40.72%562K | 5,331.91%2.55M | 1,060.49%940K |
| -Change in receivables | ---4K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | -56.80%391K | ---- | ---- | ---- | ---- | --905K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -31.47%-1.46M | 61.10%-648K | -94.81%-263K | -156.57%-4.16M | -99.20%-1.25M | -7.36%-1.11M | -4,371.79%-1.67M | ---135K | -75.81%-1.62M | -1,206.25%-627K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 7,579.41%2.61M | -93.33%173K | 0 | -11.99%3.06M | -91.61%112K | -85.02%34K | 35.33%2.59M | 322K | 277.22%3.48M | 1.34M |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --2.59M | --539K |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -21.35%722K | ---- |
| Proceeds from stock option exercised by employees | 2,579.41%911K | -93.33%173K | --0 | 1,789.51%3.06M | 51.35%112K | -61.36%34K | --2.59M | --322K | 3,950.00%162K | --74K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 7,579.41%2.61M | -93.33%173K | --0 | -11.99%3.06M | -91.61%112K | -85.02%34K | 35.33%2.59M | --322K | 277.22%3.48M | --1.34M |
| Net cash flow | ||||||||||
| Beginning cash position | -99.29%21K | -75.73%496K | -59.13%759K | --1.86M | 65.01%1.9M | 51.97%2.97M | --2.04M | --1.86M | --0 | 2,293.75%1.15M |
| Current changes in cash | 207.26%1.15M | -151.24%-475K | -240.64%-263K | -159.13%-1.1M | -260.59%-1.14M | -33.37%-1.08M | --927K | --187K | 1,857,100.00%1.86M | 1,571.93%708K |
| End cash Position | -38.08%1.17M | -99.29%21K | -75.73%496K | -59.13%759K | -59.13%759K | 65.01%1.9M | 51.97%2.97M | --2.04M | --1.86M | --1.86M |
| Free cash from | -31.47%-1.46M | 61.10%-648K | -94.81%-263K | -156.57%-4.16M | -99.20%-1.25M | -7.36%-1.11M | -4,371.79%-1.67M | ---135K | -75.81%-1.62M | -1,206.25%-627K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.